First Time Use of SD-809 in Huntington Disease
- Study Title
- First Time Use of SD-809 in Huntington Disease
- Teva Identifier
- SD-809-C-15
- ClinicalTrials.gov Identifier
- NCT01795859
- Study Status
- Completed
- Trial Condition(s)
- Chorea
- Interventions
- Drug: SD-809 | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 08/05/2013 - 12/05/2014
- Phase
- Phase 3
